SCHEMBL7401135

SCHEMBL7401135

Clc1cccc2c1ncc1c(Cl)ccn12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAVCR2 Q8TDQ0 1/20 0.34
GRM2 Q14416 1/20 0.34
LCK P06239 3/20 0.33
NR4A2 P43354 1/20 0.33
RPS6KA5 O75582 4/20 0.33
MET P08581 2/20 0.33
RPS6KA4 O75676 1/20 0.33
PTPN1 P18031 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRB2 P47870 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRE P78334 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1079672 0.84 LCK (0.36) HAVCR2GRM2LCKNR4A2RPS6KA5
SCHEMBL3789430 0.80 LCK (0.40) LCKRPS6KA5RPS6KA4DYRK1A
SCHEMBL8569861 0.79 ALDH1A1 (0.54) HAVCR2GRM2LCKNR4A2PTPN1
SCHEMBL8563723 0.75 CNR2 (0.39) LCKMEN1KMT2A
SCHEMBL8562733 0.75 DRD2 (0.49)
SCHEMBL8565094 0.74 DHFR (0.40) GRM2LCKKMT2A
SCHEMBL30049664 0.73 FGFR1 (0.40) HAVCR2METGABRPGABRDGABRA1
SCHEMBL28600838 0.73 FGFR1 (0.40) HAVCR2METGABRPGABRDGABRA1
SCHEMBL2460831 0.73 FGFR1 (0.36) HAVCR2GRM2LCKFGFR1MEN1
SCHEMBL3790285 0.72 SMN1; SMN2 (0.46) GABRA1GABRA5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001014381-A1 ETHER DERIVATIVES OF PYRROLO[1,2-A]QUINOXALINES, METHOD FOR PRODUCING THEM AND THEIR USE IN THERAPY UNIVERSITE DE CAEN BASSE-NORMANDIE (FR) 2001-03-01 WO disclosed
EP-0623620-B1 5-HT3 Pyrrolopyrazine derivatives ADIR (FR) 1998-09-09 EP disclosed
US-5599812-A ANTISEROTONINE AGENTS ADIR ET COMPAGNIE (FR) 1997-02-04 US disclosed
EP-0623620-A1 5-HT3 Pyrrolopyrazine derivatives ADIR ET COMPAGNIE (FR) 1994-11-09 EP disclosed